Ameloblastomas are rare, odontogenic tumors derived from odontogenic ectoderm. Ameloblastomas represent about 1% of all jaw tumors, but they are the second-most common odontogenic tumor. This activity outlines the evaluation and management of ameloblastoma and explains the role of the interprofessional team in evaluating and treating patients with this condition.

**Objectives:**
- Describe the pathophysiology of ameloblastoma.
- Outline the typical presentation of a patient with malignant ameloblastoma.
- Identify the most common adverse events associated with malignant ameloblastoma.

- Explain the importance of collaboration and communication amongst the interprofessional team to ensure appropriate selection of candidates for malignant ameloblastoma surgery and to enhance postoperative management.